Duration of neoadjuvant androgen deprivation therapy before radical prostatectomy and disease-free survival in men with prostate cancer
- 1 August 2001
- journal article
- Published by Elsevier BV in Urology
- Vol. 58 (2), 71-77
- https://doi.org/10.1016/s0090-4295(01)01245-6
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- NEOADJUVANT HORMONAL THERAPY BEFORE RADICAL PROSTATECTOMY AND RISK OF PROSTATE SPECIFIC ANTIGEN FAILUREJournal of Urology, 1999
- CUOG randomized trial of neoadjuvant androgen ablation before radical prostatectomy: 36-month post-treatment PSA resultsUrology, 1999
- RANDOMIZED COMPARATIVE STUDY OF 3 VS 8 MONTHS OF NEOADJUVANT HORMONAL THERAPY PRIOR TO RADICAL PROSTATECTOMYJournal of Urology, 1999
- Prolonged neoadjuvant combined androgen blockade leads to a further reduction of prostatic tumor volume: three versus six months of endocrine therapyUrology, 1999
- NEOADJUVANT ANDROGEN ABLATION FOR LOCALIZED PROSTATIC CANCER: PATHOLOGY METHODS, SURGICAL END POINTS AND META-ANALYSIS OF RANDOMIZED TRIALSJournal of Urology, 1998
- HORMONAL TREATMENT BEFORE RADICAL PROSTATECTOMY: A 3-YEAR FOLLOWUPJournal of Urology, 1998
- Preliminary results of a prospective randomized study comparing radical prostatectomy versus radical prostatectomy associated with neoadjuvant hormonal combination therapy in T2–3 N0 M0 prostatic carcinomaUrology, 1997
- Biochemical and Pathological Effects of 8 Months of Neoadjuvant Androgen Withdrawal Therapy Before Radical Prostatectomy in Patients with Clinically Confined Prostate CancerJournal of Urology, 1996